BENECCHI CHRISTOPHER (Chief Commercial Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/7/2024ACC: 0001562180-24-006086
Officer· Chief Commercial Officer
Since Sep 2021
+11.45K
Net shares
Net buyer
$42.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
16.20K acquired · 4.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.20K
Price / share
—
Trade value
—
% of position
230.0%
8/5/2024
7.04K→23.24K
Common Stock
Direct
Shares
−4.75K
Price / share
$8.96
Trade value
$42.60K
% of position
20.5%
8/5/2024
23.24K→18.49K
Total
Net shares
+11.45K
Net value
-$42.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2024 | A · Award | +16.20K | — | — | 230.0% | 7.04K | 23.24K |
| Common Stock Direct | 8/5/2024 | F · Tax Withholding | −4.75K | $8.96 | $42.60K | 20.5% | 23.24K | 18.49K |
| Total | +11.45K | -$42.60K | ||||||
Derivative Transactions0
No derivative transactions reported